Nitric oxide metabolites in cystic fibrosis lung disease - sprookjes - yvandenbroek - TriplyDB

Nitric oxide metabolites in cystic fibrosis lung disease

Nitric oxide metabolites in cystic fibrosis lung disease

http://www.wikidata.org/entity/Q42279678

about

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum Exhaled nitric oxide measurements: clinical application and interpretation Breath analysis as a potential and non-invasive frontier in disease diagnosis: an overview Arginase and pulmonary diseases Global regulator Anr represses PlcH phospholipase activity in Pseudomonas aeruginosa when oxygen is limiting Anr and its activation by PlcH activity in Pseudomonas aeruginosa host colonization and virulence Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy.Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions.Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum.Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway.Cystic fibrosis lung disease: the role of nitric oxide.ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.Oral streptococci and nitrite-mediated interference of Pseudomonas aeruginosa.Analysis of expired air for oxidation products.Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers.Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis.Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung.Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide.Increased carbon monoxide in exhaled air of patients with cystic fibrosis.Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis.Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis.Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.Effective mucus clearance is essential for respiratory health.Nitrite reductase is critical for Pseudomonas aeruginosa survival during co-infection with the oral commensal Streptococcus parasanguinis.A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation Stimulated nitric oxide production and arginine deficiency in children with cystic fibrosis with nutritional failure.Dietary Nitrate Acutely and Markedly Increased Exhaled Nitric Oxide in a Cystic Fibrosis Case.Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa.Cystic fibrosis-related oxidative stress and intestinal lipid disorders.Biofilms and host response - helpful or harmful.Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.Stratified growth in Pseudomonas aeruginosa biofilms.Myeloperoxidase and protein oxidation in cystic fibrosis.Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.Diagnostic value of exhaled carbon monoxide as an early marker of exacerbation in children with chronic lung diseases.Concentration of the antibacterial precursor thiocyanate in cystic fibrosis airway secretions.Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance.Basal and induced NO formation in the pharyngo-oral tract influences estimates of alveolar NO levels.

P2860

Q24551181-B99A6167-3C08-4E3E-A83E-0F4D29B49F75 Q24678466-6FA54B15-9F77-4135-BD02-6BEA41A08B94 Q24678480-025CE1A9-2CF3-4379-8FEB-644A25CB053B Q28085084-2FBD4475-CE7D-4652-B82B-1D86ADC127BB Q28385094-E22CB819-F109-4C46-86E3-AF0DE1DA1E91 Q28492516-FD3F24AB-AF16-49B8-AAE4-F597F222BFD3 Q28492858-F482862B-2D8E-4D78-BC27-D09DAF8BC042 Q30308607-FC0AFE4A-267C-4A8D-A691-1ACEA41722EE Q30447266-9AEE83D9-71D7-4684-98A0-5D16112AA14D Q30868724-8968298C-C04F-46BB-B72A-827A27F4DFE9 Q33523793-AB78DFDD-3538-46DF-8516-D45E9DFEE3D7 Q33787847-AE888934-0502-4E3B-BC69-FA6BEDB0BEEA Q34409752-1EEDB4F9-F594-47F4-9B0D-D15E2F29D0E8 Q34889601-0AD91A0A-967E-4F27-BF2B-B0226FCC6E14 Q35019719-92212682-A333-4EF8-B63F-6585C0061073 Q35043722-2251D2D9-C7CC-4DDC-AA96-17CCB0A7BA21 Q35087604-02D9EC1E-1341-4A09-815B-F336A6F90E90 Q35124468-C9C95B9D-16A2-4555-A314-CC186C721F3D Q35532597-45A1B918-402B-45B0-A7D9-EAAD83217B81 Q35532841-9CF8CFF1-0E79-4EB3-8842-6F39C4C65A8E Q35533642-E84FB4F8-4ABB-4347-82CF-BE59DDC30323 Q35537039-7C481D96-A448-41AB-942B-53122EC6F76E Q36203136-594F2D2A-16C8-431B-9713-C580BA9DE95E Q36346231-052CCFB5-7486-428E-A126-5AC80FD28340 Q36417678-720E3394-2B1D-4B51-9613-3E694F7D765C Q36616248-0139D03C-BDBE-4B52-A2D4-C2151E0B104A Q36756544-AFAED7BA-DED1-409E-B575-91B383FA1CCC Q36867942-866ABB48-0EA9-4F8E-BEE8-5499F64DB1DD Q37636155-3D951A2B-6027-4103-8A36-C253B543BD04 Q37721418-697F3713-667C-412C-819D-D40C7074400A Q38328252-862F3B89-832E-437C-8E41-F43ED5DF5EA2 Q39240791-D31050E3-3AC7-4E0A-B98C-0331A1F80228 Q40116694-BF070374-B3A6-4733-9007-2D771226DDD6 Q40172940-C612C194-D0CD-4554-B223-0ABDCA865FAE Q40859174-D0752AA7-3DD0-44B6-BAA0-2BC081B735EF Q40968095-A69E00DF-C082-42A7-9F18-3F9F15B970F0 Q41819782-D0AE8FA8-0159-452F-A030-23E69E0853C5 Q42015351-1D658B5C-0B82-4596-A386-F0B72FECA0F3 Q42025418-32136FD8-ECCE-4BC8-AA4A-4ECA9D73643B Q42445595-565161B7-7687-4DE3-BC14-919517FC1F87

P2860

Nitric oxide metabolites in cystic fibrosis lung disease

http://www.wikidata.org/entity/Q42279678

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Nitric oxide metabolites in cystic fibrosis lung disease

@en

Nitric oxide metabolites in cystic fibrosis lung disease

@nl

type

label

Nitric oxide metabolites in cystic fibrosis lung disease

@en

Nitric oxide metabolites in cystic fibrosis lung disease

@nl

prefLabel

Nitric oxide metabolites in cystic fibrosis lung disease

@en

Nitric oxide metabolites in cystic fibrosis lung disease

@nl

P1433

Q42279678-DB14F062-5060-4CE0-AF25-FF4BC62D92FE

P1476

Q42279678-999C0C87-A500-4EAD-A0DC-6AE7ABBC4C03

P2093

Q42279678-01A75168-5EAE-445A-9BF3-5D5D7A2328E5

Q42279678-0B7EF3A3-BE3E-4982-A504-A9F9F3D3298C

Q42279678-4B82AF6F-A0F1-4C4B-B7A6-276A6567E29F

Q42279678-782261A3-9A27-4EB7-B2E4-F7742A8E5289

Q42279678-B00D1027-0348-43D4-9B79-D436C31F5BD5

Q42279678-B3F97154-4AE6-4324-A3EA-957A56FEC944

P2860

Q42279678-0327132A-5993-4300-AF66-02206856FA7E

Q42279678-0A2F49CF-B3C9-4EE5-A7E8-156A7633EB70

Q42279678-194F4FB7-3A90-4F92-9774-196B5BC1F184

Q42279678-2497C985-4FF5-44A3-BE37-0328F8160E73

Q42279678-259C89BA-A234-4C2F-8DEC-E56116416A0D

Q42279678-42B9D0C1-FF53-4A17-A901-065FE8265D9F

Q42279678-6CAB853E-CB51-46C5-9849-DF0C7C768609

Q42279678-74B5180B-BDEF-4570-8F75-C2CA7323E6EE

Q42279678-770A41D5-1CCE-43B8-B210-8FF36106AE85

Q42279678-7B9F4204-2A51-4809-B4CA-FB8DBF17E821

P304

Q42279678-17496FFF-82BB-40E0-AE16-A69449FDE5F3

P31

Q42279678-0EE463AA-7BF9-42B6-BCF7-C37116B3667A

P356

Q42279678-4DCAEA1D-DCC5-4225-9DFD-63AF46502CD9

P407

Q42279678-964112BB-3FB1-4981-B611-C7A3138E6227

P433

Q42279678-E0952996-F948-4CB7-B702-A0401B3C34F6

P478

Q42279678-41371CD9-2727-4F74-B35A-8E78E4392283

P577

Q42279678-E33896C3-FCC3-407E-B530-CF1CC23B4989

P5875

Q42279678-665D5FB2-024F-4999-B863-D72CE2455701

P698

Q42279678-08E99703-87AB-43D7-93CD-65619ED6B470

P921

Q42279678-12DF6351-91F5-47B5-90B7-4D52489B61BD

P932

Q42279678-9B245BF3-D7F7-44F8-92E6-C7B16E26B456

P356

P1433

Archives of Disease in Childhood

P1476

Nitric oxide metabolites in cystic fibrosis lung disease

@en

P2093

Grasemann H

http://www.w3.org/2001/XMLSchema#string

Ioannidis I

http://www.w3.org/2001/XMLSchema#string

Ratjen F

http://www.w3.org/2001/XMLSchema#string

Rubin BK

http://www.w3.org/2001/XMLSchema#string

Tomkiewicz RP

http://www.w3.org/2001/XMLSchema#string

de Groot H

http://www.w3.org/2001/XMLSchema#string

P2860

Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans.

Nitric oxide production in critically ill patients.

Reduced upper airway nitric oxide in cystic fibrosis.

Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells

Nitric oxide and lung disease.

Measurement of exhaled nitric oxide in man.

Metabolic regulation including anaerobic metabolism in Paracoccus denitrificans.

P304

49-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ADC.78.1.49

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

1998-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51327027

http://www.w3.org/2001/XMLSchema#string

P698

9534676

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

1717443

http://www.w3.org/2001/XMLSchema#string